Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Aspirin vs Clopidogrel for Long-Term Maintenance After Coronary Stenting in Patients With Diabetes
- Subclinical Coronary Atherosclerosis and the Risk for Myocardial Infarction
- Separate and Combined Effects of Semaglutide and Empagliflozin on Kidney Oxygenation and Perfusion in People With Type 2 Diabetes
- Changes in Cardiorespiratory Fitness and Survival in Patients With or Without CVD
- Inflammation Contributes to Cardiovascular Risk in Patients Receiving Statin Therapy
- Differential Effect of Anticoagulation According to Cognitive Function and Frailty in Older Patients With Atrial Fibrillation
- Risk of Incident Diabetes After COVID-19 Infection
- Effect of a Longer Time in Blood Pressure Target Range on Cardiovascular Outcomes Among Patients With Type 2 Diabetes
- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
- No Benefit Observed With Night-Time Dosing vs Morning Dosing for Antihypertensive Medications